MRI Software, a global leader in real estate software and services, today announced two new solutions within MRI Agoraâ„¢, its AI-powered real estate platform. The first, MRI Agora Intelligence, delivers proactive portfolio signals and recommended actions to the people who need them. The second,
MRI
GE HealthCare (Nasdaq: GEHC) has today announced the completion of its Phase I clinical development program for a first-of-its-kind manganese-based macrocyclic magnetic resonance imaging (MRI) contrast agent. The results, which will be used to support ongoing clinical development, concluded that in a first-in-human study, this manganese-based contrast agent was well











